SHIRLEY BREEDLOVE: Open Payments
NPI 1811911407 · HOMER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 18 payments from 11 companies in 2025. Trend: 2023 $490 · 2024 $382 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $73 |
| Amgen Inc. | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| CSL Behring | 1 | $30 |
| Dynavax Technologies Corporation | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| KYOWA KIRIN, INC. | 1 | $17 |
Products named: MOUNJARO, OTEZLA, BREZTRI, Hizentra, TRELEGY ELLIPTA, Heplisav-B, Ozempic, SHINGRIX.
Industry payments across GA — which companies pay providers there.
